Position in APGE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$124,936,492
+$54,955,198 QoQ
Shares Held
941,283
+13.2% QoQ
Ownership
1.24%
of shares outstanding
% of Portfolio
0.41%
of 13F equity value
Holder Rank
#21
of 285 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MERCER GLOBAL ADVISORS INC /ADV holds $289,555,609 across 340 Biotechnology names. APGE ranks #1 (43.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | APGE |
Apogee Therapeutics, Inc.
This page
|
941,283 | $124,936,492 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
30,435 | $15,117,977 | |
| 3 | INCY |
Incyte Corp
|
116,069 | $13,157,581 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
20,094 | $12,529,412 | |
| 5 | CAPR |
Capricor Therapeutics, Inc.
|
402,731 | $9,697,762 | |
| 6 | EXEL |
Exelixis, Inc.
|
175,488 | $9,548,302 | |
| 7 | ORMP |
Oramed Pharmaceuticals Inc.
|
1,910,540 | $9,189,697 | |
| 8 | CORT |
Corcept Therapeutics Inc
|
102,823 | $8,940,459 |
All Filings in APGE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $124,936,492 | 941,283 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $69,981,294 | 831,428 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $67,227,394 | 890,665 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $38,561,183 | 970,581 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $35,628,929 | 820,376 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $61,277,124 | 1,640,180 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $32,620,575 | 720,101 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||